Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE551C01028

Trade

Corporate Actions

13 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

Results

View Details

18 Jan , 2023

12:00 AM

Rights

View Details

11 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2022

12:00 AM

Results

View Details

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Sep , 2022

12:00 AM

AGM

Announcement date: 12 Sep , 2022

View Details

28 May , 2022

12:00 AM

Dividend

Dividend amount: 0.5
Announcement date: 28 May , 2022

View Details

26 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jul , 2022

12:00 AM

Results

View Details

18 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Sep , 2022

12:00 AM

BookCloser

View Details

Shukra Pharmaceuticals Ltd News and Update

Mamaearth puts IPO plan on hold: Reports

27 March, 2023 |
4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Adani Power sells Support Properties Private Ltd to AdaniConnex

IIFL News Service |
24 March, 2023 |
4:03 PM

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	984.50	91.65	2,37,702.12	486.73	1.01	4,549.90	108.48
Dr Reddys Laboratories Ltd	4,590.70	32.21	76,011.74	324.60	0.66	3,879.60	1,156.21
Divis Laboratories Ltd	2,821.75	31.54	74,827.63	310.90	1.06	1,689.83	454.85
Cipla Ltd	889.65	25.90	71,662.87	678.52	0.56	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,538.00	49.69	52,113.83	229.00	1.56	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shukra Pharmaceuticals Ltd

Dakshesh Ramesh Shah
Managing Director

Payal Mehta
Director

Sujay Mehta
Executive Director

Bhoomiben Patel
Independent Director

Ashvin Trivedi
Director

Arpita Kabraa
Company Sec. & Compli. Officer

Rai Kavoorguthu Konark
Addtnl Independent Director

Summary

Summary Info Not Found

Reports by Shukra Pharmaceuticals Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Shukra Pharmaceuticals Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Shukra Pharmaceuticals Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 31 March , 2023 | 09:47 AM

Knowledge Center

Shukra Pharmaceuticals Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Shukra Pharmaceuticals Ltd

Dakshesh Ramesh Shah

Payal Mehta

Sujay Mehta

Bhoomiben Patel

Ashvin Trivedi

Arpita Kabraa

Rai Kavoorguthu Konark

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
31 March , 2023 | 09:47 AM